2017年12月2日

美國東部時間2017年12月1日22:58 bioortfolio報告摘要Esperance Pharmaceuticals Inc Esperance是一家腫瘤學產品的開發商。這家公司開發和銷售治療癌症的藥物。其產品包括EP100肽綴合物、EP200肽綴合物、EP300肽綴合物和抗體藥物綴合物。Esperance開發用於治療卵巢、乳腺、子宮內膜、前列腺、胰腺、實體瘤和血癌的藥物。公司采用陽離子溶肽技術平台進行藥物開發。它開發了一種被稱為膜幹擾肽的靶向癌症治療方法來殺死癌細胞。Esperance總部位於美國德克薩斯州休斯頓。Esperance Pharmaceuticals Inc醫藥保健交易和聯盟簡介為您提供有關該公司並購交易、合作夥伴關係和融資的全麵數據和趨勢分析。該報告提供了公司在五年內記錄的並購、股權/債務發行、私募股權、風險融資和合夥交易的詳細信息。該報告提供了詳細的比較數據，將交易數量及其價值按交易類型、細分行業和地區分類。 GlobalData derived the data presented in this report from proprietary inhouse Pharma eTrack deals database, and primary and secondary research. Scope Financial Deals Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships. Deals by Year Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period. Deals by Type Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc. Deals by Region Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America. Deals by Subsector Chart and table showing information on the number of deals and value reported by the company, by subsector. Major Deals Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's major public companies key financial metrics and ratios. Business Description A brief description of the company's operations. Key Employees A list of the key executives of the company. Important Locations and Subsidiaries A list and contact details of key centers of operation and subsidiaries of the company. Key Competitors A list of the key competitors of the company. Key Recent Developments A brief on recent news about the company. Reasons to Buy Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period. Understand the company's business segments' expansion / divestiture strategy The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy. Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios. Equip yourself with detailed information about the company's operations to identify potential customers and suppliers. The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors. Stay uptodate on the major developments affecting the company Recent developments concerning the company presented in the profile help you track important events. Gain key insights into the company for academic or business research Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs. Note*: Some sections may be missing if data is unavailable for the company. Related Biotechnology, Pharmaceutical and Healthcare News